Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abiomed Inc Issues FY 2014 Revenue Guidance In Line With Analysts' Estimates


Thursday, 2 May 2013 07:01am EDT 

Abiomed Inc announced that for fiscal 2014, it expects revenue to be in the range of $180 million to $185 million.According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $181 million for fiscal 2014. 

Company Quote

25.4
-0.06 -0.24%
2:43pm EDT